Smiths Medical 21-8067-24 - PORT INFUSION DUAL LUMEN TITANIUM PORT DETACHED 9.6FR POLYURETHANE CATHETER LO PROFILE

The Smiths Medical 21-8067-24 Port Infusion Dual Lumen Titanium Port with Detached 9.6FR Polyurethane Catheter is designed for reliable long-term vascular access in clinical environments where dependable infusion therapy is required. This low-profile implantable port system supports dual lumen access, allowing healthcare professionals to manage compatible therapies with greater flexibility while helping reduce the need for repeated peripheral venipuncture.

Built with a titanium port body and a polyurethane catheter, this infusion port is intended for professional use in hospitals, oncology centers, infusion clinics, and other controlled medical settings. Its low-profile design supports patient comfort, while the detached catheter configuration allows clinicians to prepare and position the system according to facility protocol and patient-specific requirements.

Key Benefits

The Smiths Medical 21-8067-24 infusion port offers a practical solution for patients requiring repeated or extended venous access. The dual lumen design helps clinicians administer compatible therapies through separate access pathways when medically appropriate, supporting efficient treatment workflows.

• Dual lumen titanium port designed for controlled infusion access
• 9.6FR polyurethane catheter supports dependable vascular access applications
• Low-profile port design helps improve patient comfort after implantation
• Detached catheter configuration supports procedural flexibility
• Suitable for long-term infusion therapy in professional clinical settings
• Helps reduce repeated peripheral needle sticks for qualifying patients
• Constructed for durability and consistent performance under clinical use

Compatibility and Applications

The Smiths Medical 21-8067-24 Port Infusion System is intended for use by trained healthcare professionals in accordance with institutional policies, physician direction, and the manufacturers instructions for use. It may be used in clinical care areas where implanted vascular access devices are appropriate for the patients treatment plan.

Typical applications may include medication infusion, compatible intravenous therapy, blood sampling where approved, oncology-related treatment support, and other prescribed infusion procedures that require reliable long-term venous access. Compatibility should always be confirmed with the therapy being administered, the access needle selected, and the facilitys vascular access protocol.

Usage Guidelines

This port infusion device should be implanted, accessed, maintained, and removed only by qualified healthcare professionals trained in vascular access procedures. Prior to use, inspect the packaging and product components to confirm integrity, sterility, correct product selection, and expiration status.

Use aseptic technique during preparation, implantation, port access, dressing changes, flushing, and maintenance. Clinicians should follow the manufacturers instructions for use, institutional guidelines, and applicable clinical standards for catheter placement, lumen identification, flushing volume, locking solution, access needle selection, and monitoring for complications.

Do not use the device if the sterile package is opened, damaged, or compromised. Patient assessment, therapy compatibility, and proper placement confirmation should be completed according to the prescribing providers direction and facility policy.

Certifications and Safety Standards

The Smiths Medical 21-8067-24 Port Infusion Dual Lumen Titanium Port is manufactured for use in regulated healthcare environments and should be handled in accordance with applicable medical device standards, facility requirements, and the products official labeling. Healthcare providers should verify all certifications, approvals, and regulatory documentation through the manufacturer or authorized distributor before purchase or clinical use.

Because implanted infusion ports are used in direct patient care, adherence to infection prevention protocols, sterile handling procedures, vascular access standards, and device-specific instructions is essential for patient safety and reliable performance.

Comparison with Competitors

Compared with standard single lumen port systems, the Smiths Medical 21-8067-24 offers dual lumen functionality, which may provide added clinical flexibility for patients who require multiple compatible therapies or separate access pathways. The titanium port body supports durability, while the 9.6FR polyurethane catheter is designed for clinical vascular access applications.

Unlike higher-profile port designs, the low-profile configuration may be preferred when patient comfort and reduced prominence under the skin are important considerations. The detached catheter format may also offer procedural flexibility compared with pre-attached configurations, depending on clinician preference and institutional technique.

Typical User Profile and Application Scenarios

This product is typically used by vascular access teams, interventional radiology teams, surgeons, oncology nurses, infusion nurses, and other licensed clinicians responsible for implanted port placement and management. It is appropriate for healthcare facilities that require dependable implantable access systems for patients receiving ongoing infusion therapy.

Common scenarios may include patients undergoing long-term medication administration, oncology treatment support, repeated infusion appointments, or clinical care plans where peripheral venous access is difficult, impractical, or not preferred. Final product selection should be based on the patients anatomy, therapy plan, clinical indication, and provider judgment.

Best Practices for Use and Maintenance

For best performance, the Smiths Medical 21-8067-24 Port Infusion System should be managed using strict aseptic technique and a consistent port maintenance protocol. Clinicians should confirm proper needle placement before infusion, monitor the site for signs of infection or infiltration, and follow facility-approved flushing and locking procedures.

• Inspect the port site before each access or treatment session
• Use only compatible non-coring access needles as directed by facility protocol
• Confirm blood return and patency according to clinical guidelines
• Flush and lock each lumen as instructed by the manufacturer and facility policy
• Document lumen use, flushing, dressing changes, and patient response
• Educate patients on signs of complications and when to contact a provider
• Store unused product in a clean, dry environment according to labeling instructions

Regulatory and Safety Information

The Smiths Medical 21-8067-24 Port Infusion Dual Lumen Titanium Port with Detached 9.6FR Polyurethane Catheter is a professional medical device intended for use under the direction of qualified healthcare providers. It should not be used without proper clinical training, product knowledge, and patient assessment.

Potential risks associated with implanted vascular access devices may include infection, thrombosis, catheter occlusion, catheter migration, extravasation, bleeding, pain, device malfunction, or complications related to insertion and removal. Clinicians must follow the manufacturers instructions for use, applicable regulations, and institutional policies for safe handling, implantation, maintenance, and disposal.

How to Order

Select the Smiths Medical 21-8067-24 PORT INFUSION DUAL LUMEN TITANIUM PORT DETACHED 9.6FR POLYURETHANE CATHETER LO PROFILE and add it to your cart. Complete checkout with your preferred shipping and payment options. For bulk orders, quotes, or further assistance, contact CIA Medical customer service at (312)275-5850 or use the contact form on this page.